West Pharmaceutical Services Inc (WST)
West Pharmaceutical Services Inc is a healthcare company listed on the NYSE under the ticker WST. It develops, manufactures, and sells containment and delivery systems for injectable drugs and other healthcare products across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company operates through two segments. Its Proprietary Products segment includes stoppers, seals, syringe and cartridge components, administration systems, drug containment solutions such as vials, syringes and cartridges, self-injection devices, and related support services such as analytical lab work, packaging support, engineering development, regulatory expertise, and technical assistance. The Contract-Manufactured Products segment designs, manufactures, and assembles devices used in surgical, diagnostic, ophthalmic, injectable, and other delivery systems, as well as certain consumer products. West Pharmaceutical Services serves biologic, generic, pharmaceutical, diagnostic, and medical device customers and was founded in 1923. It is headquartered in Exton, Pennsylvania.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-WST
|
$309.79
|
-13.3% Downside
|
Fair
|
$385.33
|
7.8% Upside
|
Fair
|
Good
|
—
|
—
|
0.88
|
0.2%
|
July 23, 2026
|
46.5x
|
8.4x
|
7.8x
|
24.891 B
|
25.062 B
|
1.3%
|
99.3%
|
16.6
|
11.4%
|
84.4%
|
